ClinicalTrials.gg
CompletedNCT03798093Updated Mar 25, 2025Results posted

Echocardiography Sub-Study of the Umbilical Cord Milking in Non-Vigorous Infants Trial (MINVI)

An interventional study of Umbilical Cord Milking and Early Cord Clamping in Birth Asphyxia, sponsored by Sharp HealthCare. Completed at 1 site in United States. Open to participants aged 35 Weeks to 42 Weeks. Per ClinicalTrials.gov, last updated 2025-03-25.

Sponsored by Sharp HealthCare · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
227
Allocation
Randomized
Ages
35 Weeks to 42 Weeks
Sex
All
01

Study summary

Non-vigorous infants enrolled in the MINVI trial will be approached for consent for ongoing data collection. As part of the data collection, an optional echocardiogram will be performed if the parent consents.

Read the detailed description

Non-vigorous infants enrolled in the MINVI trial will be approached for consent for ongoing data collection. As part of the data collection, an optional echocardiogram will be performed if the parent consents. The consent will have a check box to indicate if they consent to the additional test.

Echocardiographic measurements will be performed on all infants at 12 hours +/- 6 hours of age by our research sonographers who are blinded to infant randomization. Measurements will be taken according to a standard operating procedure to assess systemic blood flow, by superior vena cava (SVC) flow (ml/kg/min), right ventricular output (ml/kg/min), left ventricular output (LVO) (ml/kg/min), measures of left and right ventricular tissue Doppler and strain imaging. These measurements will be performed offline at a later time. Data will be entered into REDCap.

If any structural abnormalities are found, the attending pediatrician will be notified of the abnormal echocardiogram. The consent will clearly state that this echo is not for diagnostic purposes. Any additional studies including an official complete echocardiogram and or cardiology consultation will be left to the discretion of the attending pediatrician, as he/she deems necessary

02

Conditions studied

  • Birth Asphyxia

Browse trials for

Keywords

  • Umbilical Cord Milking
  • Immediate Cord Clamping
  • Resuscitation
03

In context

Asphyxia Neonatorum

106 studies on the registry are indexed under Asphyxia Neonatorum; 19 are open to participants now.

This study's enrollment of 227 is above the median of 173 across 73 interventional studies indexed under Asphyxia Neonatorum.

Browse Asphyxia Neonatorum studies →

Lead sponsor

Sharp HealthCare is the lead sponsor of 40 studies on the registry; 4 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 3 (60%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
35 Weeks to 42 Weeks
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Non-vigorous newborns born between 35-42 weeks gestation.

Exclusion criteria

Exclusion Criteria:

  • Known major congenital or chromosomal anomalies of newborn.
  • Known cardiac defects other than small atrial septal defect (ASD), ventricular septal defect (VSD) and patent ductus arteriosus (PDA).
  • Complete placental abruption/cutting through the placenta at time of delivery.
  • Monochorionic multiples
  • Cord anomaly (i.e. cord avulsion or true knot)
  • Presence of non-reducible nuchal cord
  • Perinatal providers unaware of the protocol
  • Incomplete delivery data
  • Infants born in extremis, for whom additional treatment will not be offered.
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
227 participants (actual)

Study arms

  • Active comparator
    Umbilical Cord Milking

    The delivering practitioner will place the newborn below the level of the incision (at the edge of the table) at C/S and a second team member will milk the cord four times. For vaginal delivery, the delivering obstetrician, midwife or perinatal provider will hold the infant against their body or place the infant on the mother's abdomen and the cord will be milked either four times by the obstetrical provider or by a second team member. For the cord milking procedure, the obstetrical provider will milk the entire length of umbilical cord over two seconds, repeating three additional times as described previously. This time is not significantly different from the time for Early Cord Clamping as we have demonstrated in our previous trials.

    Procedure: Umbilical Cord Milking

  • Active comparator
    Early Cord Clamping

    This will occur by clamping the umbilical cord as soon as possible. Since both Early Cord Clamping and Umbilical Cord Milking will occur after a brief assessment, it is important to note that the cord clamping time will be longer than in previously conducted preterm trials (average 20 seconds) which performed the intervention on all subjects regardless of whether or not they were vigorous. In all cases, the cord clamping time will be documented to ensure consistency.

    Procedure: Early Cord Clamping

Interventions

  • ProcedureUmbilical Cord Milking

    At delivery, the umbilical cord is grasped, and blood is pushed toward the infant 4 times before the cord is clamped. This procedure infuses a placental transfusion of blood into the infant and can be done in 15-20 seconds.

  • ProcedureEarly Cord Clamping

    The umbilical cord is clamped within 60 seconds of delivery.

06

What researchers measure

Primary outcomes

  1. Left Ventricular Output

    Left ventricular output measurements taken by cardiac ultrasound.

    Time frame: 12 ± 6 hours of life

Secondary outcomes

  1. Neonatal Right Ventricular Output

    Obtained from the modified short axis view of the neonatal echocardiogram performed at 12 hours of life ± 6 hours.

    Time frame: 12 ± 6 hours of life

  2. Neonatal Superior Vena Cava Flow

    superior vena cava (SVC) flow (Diameter obtained from the infraclavicular view (hybrid view) and doppler assessment from the subcostal view of the neonatal echocardiogram exam performed at 12 hours of life ± 6 hours.

    Time frame: 12 ± 6 hours of life

  3. Neonatal Peak Systolic Strain

    This measurement reflects the deformation (strain) of the heart muscle during systole (the phase of the heartbeat when the heart contracts) relative to its original length. More negative values indicate better myocardial function while values closer to 0 suggest impaired myocardial function.

    Time frame: 12 ± 6 hours of life

  4. Neonatal Peak Systolic Velocity

    Measure of left and right ventricular peak systolic tissue doppler velocity on neonatal echocardiogram performed at 12 hours of life ± 6 hours.

    Time frame: 12 ± 6 hours of life

Other outcomes

  1. Tricuspid Annular Plane Systolic Excursion Measurement in Neonate

    Assessment of tricuspid annular plane systolic excursion in the neonate by echocardiogram performed at 12 hours of life ± 6 hours

    Time frame: 12 ± 6 hours of life

  2. Number of Neonates With a Patent Ductus Arteriosus

    Diagnosis of patent ductus arteriosus in neonate by echocardiogram with diameter measurement and direction of flow.

    Time frame: 12 ± 6 hours of life

  3. Neonatal Direction of Ductal Shunt

    Direction of ductal shunt in neonate assessed by echocardiogram which was performed at 12 hours of life ± 6 hours.

    Time frame: 12 ± 6 hours of life

07

Results

Posted Mar 25, 2025

Participant flow

Recruitment took place at two maternity hospitals involved in a cluster crossover randomization trial of non-vigorous infants at birth randomized to perform umbilical cord milking in the initial period (January 2019-January 2020) and early cord clamping in the crossover period (February 2020- March 2021). Participants were enrolled in this study upon parental consent for a neonatal echocardiogram in the first 12 hours of life. Participants enrolled in periods 1 \& 2 are unique participants.

Initial Randomized Intervention
Participant flow — Initial Randomized Intervention
MilestoneUmbilical Cord Milking Then Early Cord Clamping Site Randomization - NeonateEarly Cord Clamping Then Umbilical Cord Milking - Neonate
Started1060
Completed1060
Not completed00
Crossover Randomized Intervention
Participant flow — Crossover Randomized Intervention
MilestoneUmbilical Cord Milking Then Early Cord Clamping Site Randomization - NeonateEarly Cord Clamping Then Umbilical Cord Milking - Neonate
Started1210
Completed1210
Not completed00

Outcome measures

PrimaryLeft Ventricular Output

Left ventricular output measurements taken by cardiac ultrasound.

Time frame:
12 ± 6 hours of life
Reported as:
Mean · mL/kg/min
Left Ventricular Output
mL/kg/minUmbilical Cord Milking - NeonateEarly Cord Clamping - Neonate
Left Ventricular Output225 ± 64187 ± 52
Statistical analysis
  • Umbilical Cord Milking - Neonate vs Early Cord Clamping - Neonate · Regression, Linear · p = 0.08 · Least squares: -0.112 · 95% CI -29.3 to 1.7
SecondaryNeonatal Right Ventricular Output

Obtained from the modified short axis view of the neonatal echocardiogram performed at 12 hours of life ± 6 hours.

Time frame:
12 ± 6 hours of life
Reported as:
Mean · mL/kg/min
Neonatal Right Ventricular Output
mL/kg/minUmbilical Cord Milking - NeonateEarly Cord Clamping - Neonate
Neonatal Right Ventricular Output284 ± 88222 ± 95
SecondaryNeonatal Superior Vena Cava Flow

superior vena cava (SVC) flow (Diameter obtained from the infraclavicular view (hybrid view) and doppler assessment from the subcostal view of the neonatal echocardiogram exam performed at 12 hours of life ± 6 hours.

Time frame:
12 ± 6 hours of life
Reported as:
Mean · mL/kg/min
Neonatal Superior Vena Cava Flow
mL/kg/minUmbilical Cord Milking - NeonateEarly Cord Clamping - Neonate
Neonatal Superior Vena Cava Flow100 ± 3686 ± 40
SecondaryNeonatal Peak Systolic Strain

This measurement reflects the deformation (strain) of the heart muscle during systole (the phase of the heartbeat when the heart contracts) relative to its original length. More negative values indicate better myocardial function while values closer to 0 suggest impaired myocardial function.

Time frame:
12 ± 6 hours of life
Reported as:
Mean · percent
Neonatal Peak Systolic Strain
percentUmbilical Cord Milking - NeonateEarly Cord Clamping - Neonate
Neonatal Peak Systolic Strain-17 ± 3-22 ± 3
SecondaryNeonatal Peak Systolic Velocity

Measure of left and right ventricular peak systolic tissue doppler velocity on neonatal echocardiogram performed at 12 hours of life ± 6 hours.

Time frame:
12 ± 6 hours of life
Reported as:
Mean · meters/second
Neonatal Peak Systolic Velocity
meters/secondUmbilical Cord Milking - NeonateEarly Cord Clamping - Neonate
Neonatal Peak Systolic Velocity.06 ± .02.07 ± .02
Other pre-specifiedTricuspid Annular Plane Systolic Excursion Measurement in Neonate

Assessment of tricuspid annular plane systolic excursion in the neonate by echocardiogram performed at 12 hours of life ± 6 hours

Time frame:
12 ± 6 hours of life
Reported as:
Mean · mm
Tricuspid Annular Plane Systolic Excursion Measurement in Neonate
mmUmbilical Cord Milking - NeonateEarly Cord Clamping - Neonate
Tricuspid Annular Plane Systolic Excursion Measurement in Neonate9.04 ± 2.29.65 ± 1.7
Other pre-specifiedNumber of Neonates With a Patent Ductus Arteriosus

Diagnosis of patent ductus arteriosus in neonate by echocardiogram with diameter measurement and direction of flow.

Time frame:
12 ± 6 hours of life
Reported as:
Count of participants · Participants
Number of Neonates With a Patent Ductus Arteriosus
ParticipantsUmbilical Cord Milking - NeonateEarly Cord Clamping - Neonate
Number of Neonates With a Patent Ductus Arteriosus88110
Other pre-specifiedNeonatal Direction of Ductal Shunt

Direction of ductal shunt in neonate assessed by echocardiogram which was performed at 12 hours of life ± 6 hours.

Time frame:
12 ± 6 hours of life
Reported as:
Count of participants · Participants
Neonatal Direction of Ductal Shunt
ParticipantsUmbilical Cord Milking - NeonateEarly Cord Clamping - Neonate
All left to right5980
All right to left01
Bidirectional2827
Post-hocDiameter of Neonatal Ductus Arteriosus

Diameter of neonatal ductus arteriosus assessed by echocardiogram which was performed at 12 hours of life ± 6 hours

Time frame:
12 ± 6 hours of life
Reported as:
Mean · cm
Diameter of Neonatal Ductus Arteriosus
cmUmbilical Cord Milking - NeonateEarly Cord Clamping - Neonate
Diameter of Neonatal Ductus Arteriosus0.19 ± 0.100.20 ± 0.10
Post-hocNeonatal Peak Pulmonary Artery Pressure

Neonatal peak pulmonary artery pressure as measured by echocardiogram at 12 hours of life ± 6 hours.

Time frame:
12 ± 6 hours of life
Reported as:
Mean · mm Hg
Neonatal Peak Pulmonary Artery Pressure
mm HgUmbilical Cord Milking - NeonateEarly Cord Clamping - Neonate
Neonatal Peak Pulmonary Artery Pressure27 ± 1527 ± 14
Post-hocMean Neonatal Blood Pressure at Time of Echocardiogram

blood pressure measurement obtained at the time of cardiac ultrasound examination

Time frame:
12 ± 6 hours of life
Reported as:
Mean · g/dL
Mean Neonatal Blood Pressure at Time of Echocardiogram
g/dLUmbilical Cord Milking - NeonateEarly Cord Clamping - Neonate
Mean Neonatal Blood Pressure at Time of Echocardiogram45 ± 746 ± 7
Post-hocMedian Neonatal Hemoglobin

Single neonatal hemoglobin measurement obtained between 12 and 48 hours of life either as part of standard care or obtained with parental written consent

Time frame:
12 to 48 hours of life
Reported as:
Mean · g/dL
Median Neonatal Hemoglobin
g/dLUmbilical Cord Milking - NeonateEarly Cord Clamping - Neonate
Median Neonatal Hemoglobin17.6 ± 2.116.5 ± 2.4

Adverse events

Collected over Assessed from neonate's birth to discharge home up to 180 days of life. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Umbilical Cord Milking - Neonate0/106 (0%)0/106 (0%)0/106 (0%)
Early Cord Clamping - Neonate0/121 (0%)0/121 (0%)0/121 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(weeks)Umbilical Cord Milking - NeonateEarly Cord Clamping - NeonateTotal
Neonatal Birth Gestational Age40 (39 to 40)39 (38 to 40)39 (38 to 40)
Age, Continuous
Age, Continuous(years)Umbilical Cord Milking - NeonateEarly Cord Clamping - NeonateTotal
Maternal Age31 (27 to 33)30 (25 to 36)31 (27 to 34)
Sex: Female, Male
Sex: Female, Male(Participants)Umbilical Cord Milking - NeonateEarly Cord Clamping - NeonateTotal
Neonatal Sex — Female455095
Neonatal Sex — Male6171132
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Umbilical Cord Milking - NeonateEarly Cord Clamping - NeonateTotal
Neonatal Ethnicity — Hispanic or Latino455297
Neonatal Ethnicity — Not Hispanic or Latino6069129
Neonatal Ethnicity — Unknown or Not Reported101
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Umbilical Cord Milking - NeonateEarly Cord Clamping - NeonateTotal
Maternal Ethnicity — Hispanic or Latino394483
Maternal Ethnicity — Not Hispanic or Latino6677143
Maternal Ethnicity — Unknown or Not Reported101
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Umbilical Cord Milking - NeonateEarly Cord Clamping - NeonateTotal
Neonatal Race — American Indian or Alaska Native000
Neonatal Race — Asian5712
Neonatal Race — Native Hawaiian or Other Pacific Islander033
Neonatal Race — Black or African American167
Neonatal Race — White5250102
Neonatal Race — More than one race283462
Neonatal Race — Unknown or Not Reported202141
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Umbilical Cord Milking - NeonateEarly Cord Clamping - NeonateTotal
Maternal Race — American Indian or Alaska Native101
Maternal Race — Asian51116
Maternal Race — Native Hawaiian or Other Pacific Islander044
Maternal Race — Black or African American2810
Maternal Race — White6458122
Maternal Race — More than one race131629
Maternal Race — Unknown or Not Reported212445
Maternal Diabetes
Maternal Diabetes(Participants)Umbilical Cord Milking - NeonateEarly Cord Clamping - NeonateTotal
Count of participants141630

19 further baseline measures are reported on the registry.

08

Study locations

1 site
  • Sharp Mary Birch Hospital for Women and Newborns
    San Diego, California 92123, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 25, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03798093
Lead sponsor
Sharp HealthCare
Collaborators
Sharp Mary Birch Hospital for Women & Newborns
Responsible party
Anup Katheria, M.D. (Director, Neonatal Research Institute, Sharp HealthCare) — Principal investigator
First posted
Jan 9, 2019
Start date
Jan 7, 2019
Primary completion
Jun 1, 2021
Completion
Nov 4, 2022
Results posted
Mar 25, 2025
Last update
Mar 25, 2025

Study contacts

Anup Katheria, MD
principal investigator · Sharp Mary Birch Hospital for Women & Newborns

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion